Equifax Inc. (EFX) financial statements: income statement, balance sheet and cash flow

Equifax Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Equifax Inc. reported revenue of $6.1B (+6.9% year on year) and net income of $664.3M (+9.4% year on year).

Income statement

Equifax Inc. income statement, fiscal years
Line itemDec 31, 2025 · FYDec 31, 2024 · FYDec 31, 2023 · FYDec 31, 2022 · FY
Operating revenue$6.1B$5.7B$5.3B$5.1B
Cost of services (exclusive of depreciation and amortization below)$2.6B$2.5B$2.3B$2.2B
Selling, general and administrative expenses$1.6B$1.5B$1.4B$1.3B
Depreciation and amortization$719.5M$669.8M$610.8M$560.1M
Total operating expenses$5.0B$4.6B$4.3B$4.1B
Operating income$1.1B$1.0B$933.6M$1.1B
Interest expense($212.3M)($229.1M)($241.4M)($183.0M)
Other income (expense), net$12.0M($2.5M)$25.7M$56.7M
Consolidated income before income taxes$894.9M$810.5M$717.9M$929.7M
Provision for income taxes($230.6M)($203.2M)($166.2M)($229.5M)
Consolidated net income$664.3M$607.3M$551.7M$700.2M
Less: Net income attributable to noncontrolling interests including redeemable noncontrolling interests($4.0M)($3.2M)($6.4M)($4.0M)
Net income attributable to Equifax$660.3M$604.1M$545.3M$696.2M
Net income attributable to Equifax (in dollars per share)$5.36$4.88$4.44$5.69
Weighted-average shares used in computing basic earnings per share (in shares)$123200000.00$123800000.00$122900000.00$122400000.00
Net income attributable to Equifax (in dollars per share)$5.32$4.84$4.40$5.65
Weighted-average shares used in computing diluted earnings per share (in shares)$124100000.00$124900000.00$123900000.00$123300000.00
Dividends per common share (in dollars per share)$1.89$1.56$1.56$1.56
Equifax Inc. income statement, quarters
Line itemSep 30, 2026 · Q3Jun 30, 2026 · Q2Mar 31, 2026 · Q1Sep 30, 2025 · Q3
Operating revenue$1.7B$1.7B$1.6B$1.5B
Cost of services (exclusive of depreciation and amortization below)$752.4M$773.7M$767.1M$663.2M
Selling, general and administrative expenses$390.4M$422.5M$411.0M$434.1M
Depreciation and amortization$194.4M$189.7M$183.1M$183.3M
Total operating expenses$1.3B$1.4B$1.4B$1.3B
Operating income$355.3M$314.2M$287.7M$264.3M
Interest expense($62.3M)($59.8M)($55.7M)($52.2M)
Other income, net$3.8M$2.5M$3.8M$3.2M
Consolidated income before income taxes$296.8M$256.9M$235.8M$215.3M
Provision for income taxes($83.4M)($71.8M)($62.5M)($53.8M)
Consolidated net income$213.4M$185.1M$173.3M$161.5M
Less: Net income attributable to noncontrolling interests including redeemable noncontrolling interests($1.7M)($1.2M)($1.8M)($1.3M)
Net income attributable to Equifax$211.7M$183.9M$171.5M$160.2M
Net income attributable to Equifax (in dollars per share)$1.80$1.55$1.43$1.30
Weighted-average shares used in computing basic earnings per share (in shares)$117300000.00$118400000.00$120000000.00$123100000.00
Net income attributable to Equifax (in dollars per share)$1.79$1.54$1.42$1.29
Weighted-average shares used in computing diluted earnings per share (in shares)$118100000.00$119200000.00$120800000.00$124100000.00
Dividends per common share (in dollars per share)$0.56$0.56$0.56$0.50

Balance sheet

Equifax Inc. balance sheet, fiscal years
Line itemDec 31, 2025 · FYDec 31, 2024 · FYDec 31, 2023 · FYDec 31, 2022 · FY
Cash and cash equivalents$180.8M$169.9M$216.8M$285.2M
Trade accounts receivable, net of allowance for doubtful accounts of $20.2 and $16.9 at December 31, 2025 and 2024, respectively$1.0B$957.6M$908.2M$857.7M
Prepaid expenses$144.2M$134.9M$142.5M$134.3M
Other current assets$74.5M$98.2M$88.8M$93.3M
Total current assets$1.4B$1.4B$1.4B$1.4B
Capitalized internal-use software and system costs$3.1B$2.8B$2.5B$2.1B
Data processing equipment and furniture$239.3M$229.6M$247.9M$281.4M
Land, buildings and improvements$299.6M$285.0M$272.9M$261.6M
Total property and equipment$3.6B$3.3B$3.1B$2.7B
Less accumulated depreciation and amortization($1.7B)($1.4B)($1.2B)($1.1B)
Total property and equipment, net$1.9B$1.9B$1.8B$1.6B
Goodwill$6.7B$6.5B$6.8B$6.4B
Indefinite-lived intangible assets$94.8M$94.7M$94.8M$94.8M
Purchased intangible assets, net$1.3B$1.5B$1.9B$1.8B
Other assets, net$347.8M$343.4M$306.2M$293.2M
Total assets$11.9B$11.8B$12.3B$11.5B
Short-term debt and current maturities of long-term debt$1.0B$687.7M$963.4M$967.2M
Accounts payable$206.4M$138.2M$197.6M$250.8M
Accrued expenses$276.3M$251.1M$245.1M$229.0M
Accrued salaries and bonuses$286.1M$215.8M$168.7M$138.7M
Deferred revenue$101.2M$115.5M$109.5M$132.9M
Other current liabilities$427.4M$403.2M$334.7M$296.6M
Total current liabilities$2.3B$1.8B$2.0B$2.0B
Long-term debt$4.1B$4.3B$4.7B$4.8B
Deferred income tax liabilities, net$390.8M$351.6M$474.9M$460.3M
Long-term pension and other postretirement benefit liabilities$103.4M$106.7M$100.1M$100.4M
Other long-term liabilities$241.1M$247.2M$250.7M$178.6M
Total liabilities$7.1B$6.8B$7.6B$7.6B
Redeemable noncontrolling interests$114.4M$105.2M$135.1M—
Preferred stock, $0.01 par value: Authorized shares - 10.0; Issued shares - none0000
Common stock, $1.25 par value: Authorized shares - 300.0;   Issued shares - 189.3 at December 31, 2025 and 2024;   Outstanding shares - 120.4 and 124.0 at December 31, 2025 and 2024, respectively236.6M236.6M236.6M236.6M
Paid-in capital$2.0B$1.9B$1.8B$1.6B
Retained earnings$6.4B$6.0B$5.6B$5.3B
Accumulated other comprehensive loss($517.1M)($722.7M)($431.2M)($473.7M)
Treasury stock, at cost, 68.3 shares and 64.7 shares at December 31, 2025 and 2024,     respectively-3.6B-2.6B—-2.7B
Stock held by employee benefits trusts, at cost, 0.6 shares at December 31, 2025 and 2024-5.9M-5.9M-5.9M-5.9M
Total Equifax shareholders’ equity$4.6B$4.8B$4.5B$4.0B
Noncontrolling interests$19.5M$17.5M$18.3M$16.8M
Total shareholders’ equity$4.6B$4.8B$4.6B$4.0B
Total liabilities, redeemable noncontrolling interests, and shareholders' equity$11.9B$11.8B$12.3B$11.5B
Equifax Inc. balance sheet, quarters
Line itemSep 30, 2026Jun 30, 2026Mar 31, 2026Sep 30, 2025
Cash and cash equivalents$192.9M$170.1M$183.4M$189.0M
Trade accounts receivable, net of allowance for doubtful accounts of $17.9 and $20.2 at September 30, 2026 and December 31, 2025, respectively$1.1B$1.1B$1.1B$1.0B
Prepaid expenses$147.5M$166.5M$184.5M$143.0M
Other current assets$142.0M$140.7M$46.9M$116.1M
Total current assets$1.6B$1.6B$1.5B$1.5B
Total property and equipment$3.5B$3.4B$3.5B$3.5B
Less accumulated depreciation and amortization($1.6B)($1.5B)($1.6B)($1.6B)
Total property and equipment, net$1.9B$1.9B$1.9B$1.9B
Goodwill$6.8B$6.8B$6.8B$6.7B
Indefinite-lived intangible assets$94.7M$94.7M$94.8M$94.7M
Purchased intangible assets, net$1.2B$1.2B$1.3B$1.4B
Other assets, net$357.5M$359.6M$356.8M$324.3M
Total assets$11.9B$12.0B$11.9B$11.8B
Short-term debt and current maturities of long-term debt$157.7M$1.4B$1.3B$759.3M
Accounts payable$115.3M$126.6M$158.4M$156.2M
Accrued expenses$300.7M$331.0M$379.0M$298.7M
Accrued salaries and bonuses$228.6M$165.9M$142.5M$245.4M
Deferred revenue$112.8M$101.2M$106.3M$110.5M
Other current liabilities$544.7M$490.5M$412.0M$413.4M
Total current liabilities$1.5B$2.6B$2.5B$2.0B
Long-term debt$5.0B$4.1B$4.1B$4.1B
Deferred income tax liabilities, net$459.9M$424.5M$401.9M$376.4M
Long-term pension and other postretirement benefit liabilities$100.9M$101.8M$102.5M$104.4M
Other long-term liabilities$253.4M$253.3M$248.5M$237.9M
Total liabilities$7.3B$7.5B$7.3B$6.8B
Redeemable noncontrolling interests$120.8M$121.5M$120.4M$118.6M
Preferred stock, $0.01 par value: Authorized shares - 10.0; Issued shares - none0000
Common stock, $1.25 par value: Authorized shares - 300.0; Issued shares - 189.3 at September 30, 2026 and December 31, 2025; Outstanding shares - 117.1 and 120.4 at September 30, 2026 and December 31, 2025, respectively236.6M236.6M236.6M236.6M
Paid-in capital$2.1B$2.1B$2.1B$2.0B
Retained earnings$6.8B$6.7B$6.5B$6.3B
Accumulated other comprehensive loss($441.2M)($460.1M)($462.2M)($551.3M)
Treasury stock, at cost, 71.6 shares and 68.3 shares at September 30, 2026 and December 31, 2025, respectively-4.2B-4.1B-3.8B-3.1B
Stock held by employee benefits trusts, at cost, 0.6 shares at September 30, 2026 and December 31, 2025-5.9M-5.9M-5.9M-5.9M
Total Equifax shareholders’ equity$4.5B$4.4B$4.5B$4.9B
Noncontrolling interests$20.5M$18.2M$21.7M$18.7M
Total shareholders' equity$4.5B$4.4B$4.6B$5.0B
Total liabilities, redeemable noncontrolling interests, and shareholders' equity$11.9B$12.0B$11.9B$11.8B

Cash flow statement

Equifax Inc. cash flow statement, fiscal years
Line itemDec 31, 2025 · FYDec 31, 2024 · FYDec 31, 2023 · FYDec 31, 2022 · FY
Consolidated net income$664.3M$607.3M$551.7M$700.2M
Depreciation and amortization$726.9M$680.6M$619.8M$568.6M
Stock-based compensation expense$78.4M$81.6M$71.8M$62.6M
Deferred income taxes$30.2M($66.9M)($70.2M)$88.1M
Gain on fair market value adjustment and gain on sale of equity investments($1.2M)$0——
Accounts receivable, net($40.9M)($66.3M)($23.3M)($138.6M)
Other assets, current and long-term$42.6M($29.5M)($13.0M)($22.4M)
Current and long-term liabilities, excluding debt$115.4M$117.7M($6.2M)($464.6M)
Cash provided by operating activities$1.6B$1.3B$1.1B$757.1M
Capital expenditures($481.4M)($511.5M)($601.3M)($624.5M)
Acquisitions, net of cash acquired($74.1M)$0($283.8M)($433.8M)
Cash received from divestitures$1.2M$0$6.9M$98.8M
Cash used in investing activities($554.3M)($511.5M)($878.2M)($959.5M)
Net short-term borrowings (payments)$474.7M$91.2M($371.2M)$242.2M
Payments on long-term debt($400.2M)($1.4B)($579.3M)($500.0M)
Proceeds from issuance of long-term debt$1.7M$649.8M$872.9M$749.3M
Treasury stock purchases($927.5M)—$0$0
Dividends paid to Equifax shareholders($232.8M)($193.2M)($191.8M)($191.1M)
Distributions paid to noncontrolling interests($6.1M)($4.6M)($45.6M)($3.1M)
Proceeds from exercise of stock options and employee stock purchase plan$46.4M$78.2M$32.3M$16.9M
Payment of taxes related to settlement of equity awards($15.0M)($16.8M)($17.3M)($33.9M)
Purchase of redeemable noncontrolling interests($900.0K)$0$0($400.0K)
Debt issuance costs$0($5.4M)($6.2M)($6.2M)
Cash used in financing activities($1.1B)($846.4M)($306.2M)$273.7M
Effect of foreign currency exchange rates on cash and cash equivalents$9.2M($13.5M)($800.0K)($10.8M)
Increase (decrease) in cash and cash equivalents$10.9M($46.9M)($68.4M)$60.5M
Cash and cash equivalents, beginning of period$169.9M$216.8M$285.2M$224.7M
Cash and cash equivalents, end of period$180.8M$169.9M$216.8M$285.2M
Equifax Inc. cash flow statement, quarters
Line itemSep 30, 2026 · YTDJun 30, 2026 · YTDMar 31, 2026 · Q1Sep 30, 2025 · YTD
Consolidated net income$571.8M$358.4M$173.3M$487.9M
Depreciation and amortization$572.6M$376.2M$184.8M$540.8M
Stock-based compensation expense$74.5M$60.5M$43.3M$63.9M
Deferred income taxes$73.5M$38.0M$13.5M$29.6M
Gain on sale of equity investment$0$0—($800.0K)
Accounts receivable, net($91.7M)($91.2M)($58.3M)($45.6M)
Other assets, current and long-term($95.7M)($119.3M)($16.3M)($10.3M)
Current and long term liabilities, excluding debt$37.1M($40.9M)($98.4M)$79.4M
Cash provided by operating activities$1.1B$581.7M$241.9M$1.1B
Capital expenditures($378.9M)($255.4M)($120.4M)($351.4M)
Cash received from divestitures$0$0—$800.0K
Cash used in investing activities($378.9M)($255.4M)($120.4M)($350.6M)
Net short-term payments($604.8M)$647.8M$214.9M($204.1M)
Payments on long-term debt($276.4M)($276.4M)($1.4M)$0
Proceeds from issuance of long-term debt$998.1M——$1.7M
Treasury stock purchases($652.0M)($560.0M)($260.0M)($427.4M)
Payment of share repurchase excise tax($8.3M)($8.3M)——
Dividends paid to Equifax shareholders($199.4M)($133.5M)($67.1M)($172.0M)
Distributions paid to noncontrolling interests($5.6M)($5.6M)—($6.2M)
Proceeds from exercise of stock options and employee stock purchase plan$23.8M$16.8M$10.4M$38.1M
Payment of taxes related to settlement of equity awards($15.7M)($15.4M)($14.5M)($13.6M)
Debt issuance costs($7.9M)($300.0K)—$0
Cash used in financing activities($748.2M)($334.9M)($117.7M)($783.5M)
Effect of foreign currency exchange rates on cash and cash equivalents($2.9M)($2.1M)($1.2M)$8.3M
Increase in cash and cash equivalents$12.1M($10.7M)$2.6M$19.1M
Cash and cash equivalents, beginning of period$180.8M$180.8M$180.8M$169.9M
Cash and cash equivalents, end of period$192.9M$170.1M$183.4M$189.0M

Equifax Inc. score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.